Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unnati Pharmaceuticals is an Indian pharmaceutical company specializing in the manufacture and supply of finished dosage formulations. The company operates a WHO-GMP certified manufacturing facility and produces a wide range of generic medicines, including beta-lactams, cephalosporins, and non-beta-lactam tablets and capsules. Its product portfolio spans multiple therapeutic areas such as anti-infectives, analgesics, anti-diabetics, and cardiovascular health. In addition to its own brand of products, Unnati Pharmaceuticals provides contract manufacturing services to other pharmaceutical firms. The company is focused on providing affordable healthcare solutions through high-quality generic drug production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unnati.